Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System
Version of Record online: 18 OCT 2012
Published 2012. This article is a U.S. Government work and is in the public domain in the USA.
Volume 108, Issue 1, pages 203–210, January 2013
How to Cite
Meyer, T. E., Taylor, L. G., Xie, S., Graham, D. J., Mosholder, A. D., Williams, J. R., Moeny, D., Ouellet-Hellstrom, R. P. and Coster, T. S. (2013), Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System. Addiction, 108: 203–210. doi: 10.1111/j.1360-0443.2012.04024.x
- Issue online: 26 DEC 2012
- Version of Record online: 18 OCT 2012
- Accepted manuscript online: 19 JUL 2012 01:13PM EST
- Manuscript Accepted: 12 JUL 2012
- Manuscript Revised: 28 MAR 2012
- Manuscript Received: 20 JAN 2012
Figure S1 Density plots of the in-patient primary discharge diagnosis-based propensity scores by cohort before and after matching
Table S1 Distribution of all characteristics considered in the propensity scores by smoking cessation therapy cohort before and after matching on the 30-day in-patient primary discharge diagnosis definition.
Table S2 Text strings evaluated in the product or generic name field for consideration in the medication history assessment.
Table S3 Variables included in propensity score models by outcome type.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.